N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituent.
Cobb JE, Blanchard SG, Boswell EG, Brown KK, Charifson PS, Cooper JP, Collins JL, Dezube M, Henke BR, Hull-Ryde EA, Lake DH, Lenhard JM, Oliver W Jr, Oplinger J, Pentti M, Parks DJ, Plunket KD, Tong WQ.
Cobb JE, et al. Among authors: brown kk.
J Med Chem. 1998 Dec 3;41(25):5055-69. doi: 10.1021/jm980414r.
J Med Chem. 1998.
PMID: 9836622